The FDA approves Johnson & Johnson's sNDA for Spravato as a monotherapy for adults with treatment-resistant depression.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...

Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to Johnson & Johnson.

It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...

The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD.

The FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe ...

Researchers have pinpointed a biological mechanism that strengthens the evidence that M. morganii influences brain health.

James Cauthen, a 54-year-old fire chief with Coweta County Fire in Georgia, was shot and killed while helping drivers who hit ...

Knowing what foods lower testosterone is just one part of eating for hormonal health. It might also help to prioritize foods ...